GlaxoSmithKline have scored another Victory...

July 2010, Warren Matthews

Summary

Today the US FDA voted to allow GSK's money-making diabetic drug Avandia to remain on the market. However, not everyone on the FDA review panel agreed.

Today the US FDA voted to allow GSK's money-making diabetic drug Avandia to remain on the market. However, not everyone on the FDA review panel agreed.

In fact, out of the 33 panel members, 12 of them wanted to withdraw it, and 10 wanted it to remain on the market with serious revisions to the label. Other than one other member abstaining, the rest were happy to continue 'business as is'.

Hmm...I bet there was a bit of lobbying going on before the vote was made! Is this drug really necessary? Obviously there are widely different opinions about this. One thing that I can safely say is that it should only be a drug of last resort, when the basics (which usually work) have failed...such as diet and exercise.

Unfortunately, Avandia - like so many drugs - is prescribed as the first line of action by many doctors rather than them spending the time to help educate their patients about lifestyle changes to eliminate the cause of the disease and avoid the drug dependency.

You can find out more by reading this article...

Leave a Comment

Topics you might be interested in


Show Your Body Some Love – Drink Up!

November 2018 by, Xtend-Life Expert

Our bodies are made up of about 75 percent water, and we need it for virtually every function, including thinking. Research shows that those who drink two glasses of water...

Read More

Preventing Winter Illness

October 2018 by, Xtend-Life Expert

Around this time of year when the temperature drops, we usually warn ourselves about the arrival of the flu season. Preventing winter colds and flu is about strengthening the immune...

Read More